Clinical operations note: globus-medical-benefits-a-buyers-perspective-on-excelsiusgps-and-medical-device-purchasing-149

I manage purchasing for a two-site ambulatory surgery center and three outpatient clinics. In 2024 we ran about $5.2 million through the medical device and supply budget — maybe $5.6 after the imaging expansion, I'd have to check the final year-end report. If you're weighing Globus Medical for your approved vendor list, my short answer is yes. But the Globus Medical benefits that show up in my spreadsheets are not the ones the marketing deck leads with.

The benefits that matter at my level are process benefits: fewer invoice mismatches, contract pricing that matches what we are actually billed, reimbursement paperwork we don't have to chase, and a far more transparent capital purchase process for the Globus Medical ExcelsiusGPS than we've had with most surgical technology. That's unglamorous. It's also the reason nobody in finance regrets the purchase.

I've been managing vendor relationships since early 2020. The clinical fundamentals haven't changed much: a device has to do what it claims, and someone has to support it when something goes wrong. What changed is the buying environment. Regulatory paperwork, service contracts, training, vendor qualification — the vendors who handle those well make my job easy. The ones who don't make my job miserable.

Globus Medical benefits I can actually measure

We added Globus Medical in 2022 after our spine surgeons asked for a wider implant catalog. From the purchasing side, what sold me was the contract structure: one agreement covered multiple implant systems and the associated instruments. One field team. One purchase order. One service contact. When the Globus–NuVasive merger closed in 2023, the catalog got broader and the consolidation case got stronger.

The Globus Medical benefit that surprised me was quieter. Here's something vendors don't advertise: regulatory and reimbursement support is mostly back-office work. It means someone answers our billing team's questions before we submit, pulls the FDA documentation we need, and makes sure marketing language aligns with what the device is actually cleared for. That's not thrilling, but it prevents delays that cost real money.

If a vendor can't show you its documentation before the sale, it won't get better after the sale.

Globus Medical ExcelsiusGPS: what a capital purchase really involves

Most people ask whether the ExcelsiusGPS is “worth it.” I'm not a surgeon, so I won't give a clinical opinion. What I can tell you is how I evaluated it from a procurement seat.

First, I checked the FDA 510(k) database myself. It's public, and it tells you exactly what a device is cleared for. When a company's marketing language lines up with the clearance language, that tells you something about how they operate. As of January 2025, I still do this for any major capital device, no matter which manufacturer is pitching.

Second, I looked at three years of expected costs, not just the quote. The counterintuitive piece: the hardware is not the biggest number. Service contract, staff training, planned maintenance, and case-specific accessories add up quickly. People think surgical navigation is expensive because of the robot. In practice, the recurring costs around the robot are where the total cost of ownership is decided. If a vendor won't put those in writing, keep negotiating.

Third, be honest about utilization. We did not buy ExcelsiusGPS expecting it to be used on every case. We bought it for the cases where our surgeons expect it to add the most value. That discipline matters because utilization is what lets you defend a capital purchase in a budget review. It also sets realistic expectations for the OR team.

What I check before buying a blood analyzer

I use the same framework for smaller pieces of equipment. When our main clinic needed a blood analyzer, I started with the usual number: tests per hour. A 300-test-per-hour analyzer looked like the obvious winner. But our lab runs maybe 70–90 CBCs per day plus a handful of panels. The blood analyzer we selected was slower, and it was a better fit in terms of the assay menu, reagent flexibility, service cost, and physical footprint. We bought for actual workflow, not the spec sheet.

I learned that lesson the hard way. In 2021, a vendor offered a blood analyzer at what looked like a great price. The catch showed up after the sale: their invoicing did not work with our purchase order system, finance rejected about $2,400 in expenses, and I had to explain it to my VP. Now the first thing I check is the vendor's billing and service infrastructure, not the analyzer's brochure. The reagent and maintenance contract is second. The hardware is a distant third.

Here is the short checklist:

• Assay menu — what you will actually run, not the full menu the instrument can handle.
• Reagent contract — open or closed system, minimum monthly purchases, cost per result.
• CLIA complexity — waived analyzers are much easier to staff than moderate-complexity systems.
• Service model — planned maintenance, expected downtime, and response time in your region.

Buying a laparoscope: the boring details win

When our general surgery program needed its first laparoscope set, I expected the debate to be all about image quality. It was, partly. But the purchase came down to three less exciting questions: Would the scope and camera head work with the stack we already owned? Could the vendor cover us if a scope was damaged — laparoscopes get dropped — and was there a loaner? And which configuration would the surgeons actually reach for most days? For our team, that was a 10 mm, 30-degree scope. The specialty scopes came later, only when cases justified them.

The resolution argument will dominate your first meeting with any surgical sales rep. That's fine. Just remember that a laparoscope with a great image doesn't help you if it is being repaired for three weeks and there's no backup. Ask about the repair and loaner process before you ask about pixels.

“How does a centrifuge work?” — and why buyers should know

I hear that question from new lab staff at least once a year, and it isn't a silly one. A centrifuge spins tubes around a central axis, generating relative centrifugal force, or g-force. Denser material, such as red blood cells, is pushed outward and settles at the bottom of the tube. Lighter material, such as plasma or serum, stays closer to the top. That density-based separation is the basis for many routine lab tests.

When you buy a centrifuge, compare maximum RCF, not just RPM. Two centrifuges can spin at the same RPM but produce very different g-forces if the rotor radius differs. The relationship is roughly RCF = 1.12 x 10^-5 x rotor radius (cm) x RPM^2. I'm not a physicist, so I had our lab manager double-check that equation before I put it in a budget memo. If a vendor lists only RPM, ask for the RCF at the rotor you will use. And make sure the rotor actually fits the tubes you run; that sounds obvious, but it gets overlooked more often than you'd think.

Where my advice stops applying

All of this assumes you have volume. A single clinic running a low number of samples per day doesn't need a high-throughput blood analyzer. A surgical team performing a small number of complex spine cases may not need surgical navigation at all. Buying more technology than your caseload can support is not a sign of good procurement; it's how good budgets go bad.

I also wouldn't standardize on one manufacturer for every category. Globus Medical is on our list for good reasons, but I still maintain a second source for critical supplies, and I would expect any buyer to do the same. A vendor has to prove its service coverage in your specific region. A great national reputation doesn't fix a problem if the nearest field engineer is six hours away.

Here's where I land after five years of buying devices: the industry changes faster than the fundamentals. A centrifuge still separates by density. A scope still needs light and a clear optical path. Surgery still depends on the judgment of the people holding the instruments. What has changed is how much of the value sits outside the product — in documentation, service contracts, training, and follow-through. That's where Globus Medical earned our business, and it's the standard I would hold any vendor to, from a blood analyzer to a laparoscope to an ExcelsiusGPS capital project.